mHealth Screening to Prevent Strokes

The study, launched in November 2015, is a novel multisectoral collaboration between the Scripps Research Translational Institute, Aetna's Healthagen Outcomes unit, and Janssen Pharmaceuticals, Inc.

Study participants will undergo continuous single-lead electrocardiogram (ECG) monitoring using the ZIO® XT Patch wearable sensor, developed by iRhythm Technologies. Additionally, a subset of participants will be invited to participate in a substudy that monitors heart rate and rhythm characteristics through the Amiigo wristband monitor.

Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation, Journal of the American Medical Association, July 2018

Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial, American Heart Journal, May 2016

Mobile health devices diagnose hidden heart condition in at-risk populations (Press release)

Wearable heart monitors reveal otherwise undetected atrial fibrillation, Modern Healthcare, July 2018

Wearable, At-Home Patch Could Spot A-Fib Early, WebMD, July 2018

Wearable ECG device increases AFib diagnoses, Cardiovascular Business, July 2018

Self-Applied ECG Patch Catches Atrial Fibrillation More Quickly than Usual Care, MD Magazine, March 2018

Study Launched by STSI Uses Wearable Sensors to Detect Atrial Fibrillation (Press release)